Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol Kit
Product Images NDC 0378-7296

8 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Desogestrel And Ethinyl Estradiol And Ethinyl Estradiol (NDC 0378-7296). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Desogestrel And Ethinyl Estradiol Structural Formulas (Image 01)

Desogestrel And Ethinyl Estradiol Structural Formulas (Image 01)
Packaging label for a kit of Desogestrel and Ethinyl Estradiol tablets, USP. The label indicates the strengths as 0.15 mg, 0.02 mg, and 0.01 mg. The label shows a 28-tablet supply divided into 3 pouches and is manufactured by Mylan Pharmaceuticals Inc. The label features a pink background with white floral designs and includes storage instructions and patient information reminders.*
FDA Label Image

Figure 1: Circulatory Disease Mortality Rates Per 100,000 Woman-years By Age, Smoking Status, And Oral Contraceptive Use (Image 02)

Figure 1: Circulatory Disease Mortality Rates Per 100,000 Woman-years By Age, Smoking Status, And Oral Contraceptive Use (Image 02)
A forest plot showing effect estimates (OR/RR) with 95% confidence intervals from various contraceptive studies, including NICHD Women's Contraceptive Study 2002, French E3N cohort Study 2005, Shangai Women's Health Study 2009, and others. The plot compares ever use and current use groups with values ranging approximately from 0.8 to 1.7 on the effect estimate scale.*
FDA Label Image

Figure 2: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 03)

Figure 2: Relevant Studies Of Risk Of Breast Cancer With Combined Oral Contraceptives (Image 03)
A forest plot showing effect estimates (OR/RR) with confidence intervals from multiple studies related to DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL use, including both ever and current use cases from various health studies conducted between 2002 and 2017. The horizontal axis represents the effect estimate scale ranging approximately from -1.5 to 2.*
FDA Label Image

Patient Package Insert Brief Summary Figure 1 (Image 04)

Patient Package Insert Brief Summary Figure 1 (Image 04)
The image shows a medication kit for Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol by Mylan Pharmaceuticals Inc., NDC 0378-7296. The kit features a weekly medication chart with circles for days and colored tablets: green, white to off-white, and light peach. The label includes storage instructions and the active ingredients.*
FDA Label Image

Patient Package Insert Brief Summary Figure 2 (Image 05)

Patient Package Insert Brief Summary Figure 2 (Image 05)
Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol oral contraceptive kit label. It features a weekly pill organizer layout with days of the week and arrows indicating the direction for use. The label includes the drug names, strengths (USP), storage instructions, and the product NDC number 0378-7296. An illustrated hand is shown removing a tablet from the pack.*
FDA Label Image

Patient Package Insert Brief Summary Figure 3 (Image 06)

Patient Package Insert Brief Summary Figure 3 (Image 06)
An instructional diagram showing a 28-day oral tablet kit for desogestrel and ethinyl estradiol and ethinyl estradiol. It illustrates weekly rows with circles representing daily tablet doses, including green tablets and light peach tablets, marked as white to off-white tablets and light peach tablets, respectively, with day labels Sunday through Saturday.*
FDA Label Image

Patient Package Insert Brief Summary Figure 4 (Image 07)

Patient Package Insert Brief Summary Figure 4 (Image 07)
Kit packaging label for DESOGESTREL AND ETHINYL ESTRADIOL AND ETHINYL ESTRADIOL tablets from Mylan Pharmaceuticals Inc. The label shows a weekly calendar layout with days of the week from Sunday to Saturday. It includes instructions to start on a specified day, week divisions, and dosage strength information: USP 0.15 mg / 0.02 mg and 0.01 mg per tablet. The label also mentions storage conditions and the product NDC 0378-7296.*
FDA Label Image

Desogestrel And Ethinyl Estradiol Tablets Label (Image 08)

Desogestrel And Ethinyl Estradiol Tablets Label (Image 08)
Packaging label for Desogestrel and Ethinyl Estradiol and Ethinyl Estradiol tablets, USP, with strengths of 0.15 mg, 0.02 mg, and 0.01 mg respectively. The product is an oral contraceptive kit containing 28 tablets per pouch, with 3 pouches included. The label features a pink background with white floral design, and is labeled for prescription use by Mylan Pharmaceuticals Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.